Back to Verition Fund Management LLC Verition Fund Management LLC

MRNAMRNA

Showing 7 of 23 quarters

Position history for Verition Fund Management LLCVerition Fund Management LLC's holdings in Moderna, Inc.

No. Verition Fund Management exited its MRNA (Moderna) position in Q1 2026. Its Q4 2025 13F listed 452,529 shares worth $13.3M. Verition Fund Management first reported MRNA in Q2 2020 and held it in 20 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.6M

Total Shares Change

-38,616

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$50.80
0
2025-Q4
Increased
452,529
+103.5%
$13.3M0.1%$29.49
45
2025-Q3
Decreased
222,337
-2.7%
$5.7M0.0%$25.83
0
2025-Q2
Increased
228,415
+100.2%
$6.3M0.0%$27.59
44
2025-Q1
Increased
114,068
+4.3%
$3.2M0.0%$28.35
28
2024-Q4
Increased
109,419
+183.3%
$4.5M0.0%$41.58
43
2024-Q3
Increased
38,616
+102.4%
$2.6M0.0%$65.75
42

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used